Titre:
  • Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases
Auteur:Body, Jean-Jacques; Lichinitser, Michail; Tjulandin, Sergei; Garnero, Patrick; Bergström, Bengt
Informations sur la publication:Annals of oncology, 18, 7, page (1165-1171)
Statut de publication:Publié, 2007-07
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Bisphosphonates
Bone markers
Bone metastases
Ibandronate
Zoledronic acid
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdm119
info:scp/34547840272
info:pmid/17442659